Poland· PL-100523259
Octeangin
A octenidine product containing octenidini dihydrochloridum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Octenidine is registered in 3 of 19 countries.
Countries holding a registration under ATC R02AA21 (octenidine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Octenidine · ATC R02AA21
3 / 19 countries
- Belgiumprice
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Octenidini dihydrochloridum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- R02AA21
- ATC class
- Octenidine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991583200
- gtin05909991583217
- gtin05909991583224
- gtin05909991583231
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octenidine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOCTARINSchülke & Mayr GmbH, Norderstedt
- SwitzerlandMerfen Octénidine, gelVerfora SA
- GermanyLaryngomedinCassella-Med Gmbh & Co. Kg
- BelgiumOcteangin 2.6 mgMelisana
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Octeangin, Octenidin Schülke
- Belgium · Octeangin
- Bulgaria · Октеангин
- Czechia · Octarin, Octenidine
- Germany · Laryngomedin, Octenident Antiseptic
- Estonia · Octenidine
- Croatia · Oktenidindiklorid Klosterfrau
- Hungary · Octeangin
- Lithuania · Octenidine
- Luxembourg · Laryngomedin
- Latvia · Octenidine
- Romania · Octeangin
- Slovenia · Oktenidin
- Slovakia · Octenidine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de69cf07-3951-4ff4-a628-681366b0a450 GET /v1/drugs/de69cf07-3951-4ff4-a628-681366b0a450?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pastylki twarde",
"source": "urpl",
"strength": "2,6 mg",
"packaging": "05909991583200 ¦ Rp ¦ 163397\n12 szt.\n05909991583217 ¦ Rp ¦ 163398\n16 szt.\n05909991583224 ¦ Rp ¦ 163399\n20 szt.\n05909991583231 ¦ Rp ¦ 163400\n24 szt.",
"substance": "Octenidini dihydrochloridum 2.6 mg",
"common_name": "Octenidini dihydrochloridum",
"pl_product_id": "100523259",
"pozwolenie_nr": "278/25",
"auth_procedure": "IR",
"authorisation_validity": "2030-08-25"
}See everything about octenidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.